Skip to content

A performance evaluation of OncAlertTM POC Test, an in vitro diagnostic for head and neck cancer

A performance evaluation of OncAlertTM POC Test, an in vitro diagnostic for head and neck cancer - Evaluation of OncAlertTM POC Test

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021817
Enrollment
40
Registered
2017-04-01
Start date
2018-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

None listed

Sponsors

Kanazawa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with head and neck squamous cell carcinoma

Exclusion criteria

Exclusion criteria: Patients who do not want to participate this study

Design outcomes

Primary

MeasureTime frame
Evaluation of the sensitivity and specificity of OncAlertTM POC Test[0020]before treatment

Secondary

MeasureTime frame
Evaluation of the sensitivity and specificity of OncAlertTM POC Test by original site of cancer[0020]before treatment

Countries

Japan

Contacts

Public ContactKazuhira Endo

Kanazawa University Hospital Division of Otolaryngology

endok@med.kanazawa-u.ac.jp076-265-2413

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026